Skip to main content
. 2021 Dec 23;54(2):261–270. doi: 10.3724/abbs.2021019

Figure6 .


Figure6

LIMT over-expression could suppress tumor growth in vivo (A,B) Growth curves of xenograft tumors and the tumor size treated with control, sorafenib, LIMT plasmid, or sorafenib plus LIMT plasmid (n = 3 per group). (C) TUNEL was used to analyze cell apoptosis in the treatment groups. (D) RT-qPCR was used to analyze the mRNA expression levels of E-cadherin, Vimentin and FN-1.